GLAXO.NS
GLAXO.NS
INE159A01016
GLAXOSMITHKLINE PHARMA LT
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 38.075.535.000 37.260.347.000
2.2%
Cost of Revenue 14.216.035.000 14.730.341.000
3.5%
Gross Profit 23.859.500.000 22.530.006.000
5.9%
11.383.802.000 11.386.509.000
0.0%
Operating Income 12.475.698.000 11.143.497.000
12.0%
Pretax Income 14.060.130.000 12.598.784.000
11.6%
Net Income Common Stockholders 10.359.824.000 9.275.829.000
11.7%
-- --
--
-- --
--
ende